These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9867417)
1. Life on the bio-pharm: therapeutic proteins from transgenic organisms. Cambridge Healthtech Institute's Transgenic Production of Human Therapeutics. Waltham, MA, USA, 29-30 June 1998. Tian XC; Yang XJ Mol Med Today; 1998 Oct; 4(10):424-5. PubMed ID: 9867417 [No Abstract] [Full Text] [Related]
2. Acres of antibodies: the future of recombinant biomolecule production? Sayers JR Trends Biotechnol; 2001 Nov; 19(11):429-30. PubMed ID: 11602287 [TBL] [Abstract][Full Text] [Related]
3. Producing proteins in transgenic plants and animals. Larrick JW; Thomas DW Curr Opin Biotechnol; 2001 Aug; 12(4):411-8. PubMed ID: 11551472 [TBL] [Abstract][Full Text] [Related]
5. Transgenic rabbits as therapeutic protein bioreactors and human disease models. Fan J; Watanabe T Pharmacol Ther; 2003 Sep; 99(3):261-82. PubMed ID: 12951161 [TBL] [Abstract][Full Text] [Related]
7. Cambridge Healthtech Institute's 3rd Annual Laser Capture Microscopy: cutting edge applications. May 2-3 2005, World Trade Center, Boston, MA, USA. Bhattacherjee V; Greene R; Pisano MM Expert Rev Mol Diagn; 2005 Jul; 5(4):487-91. PubMed ID: 16013966 [No Abstract] [Full Text] [Related]
8. Transgenic bioreactors. Jänne J; Alhonen L; Hyttinen JM; Peura T; Tolvanen M; Korhonen VP Biotechnol Annu Rev; 1998; 4():55-74. PubMed ID: 9890138 [TBL] [Abstract][Full Text] [Related]
9. Transgenic chickens as bioreactors for protein-based drugs. Lillico SG; McGrew MJ; Sherman A; Sang HM Drug Discov Today; 2005 Feb; 10(3):191-6. PubMed ID: 15708533 [TBL] [Abstract][Full Text] [Related]
10. Genes and the heart: a quest for new therapeutic strategies. Cambridge Healthtech Institute's First Cardiovascular Genomics Conference. Orlando, FL, USA, 11-12 January 1999. Durham NP; Hall AS Mol Med Today; 1999 May; 5(5):195-7. PubMed ID: 10454840 [No Abstract] [Full Text] [Related]
11. Molecular farming of recombinant antibodies in plants. Fischer R; Liao YC; Hoffmann K; Schillberg S; Emans N Biol Chem; 1999; 380(7-8):825-39. PubMed ID: 10494831 [TBL] [Abstract][Full Text] [Related]
13. The Cambridge Healthtech Institute's 9th Annual Conference on Blood Safety. Farrugia A Expert Opin Drug Saf; 2003 Jul; 2(4):431-5. PubMed ID: 12904099 [TBL] [Abstract][Full Text] [Related]
14. [Transgenic animals as bioreactors in the service of the pharmaceutical industry]. Honscha W Dtsch Tierarztl Wochenschr; 1999 Oct; 106(10):425-32. PubMed ID: 10589152 [TBL] [Abstract][Full Text] [Related]
16. Production of recombinant blood factors in transgenic plants. Theisen M Adv Exp Med Biol; 1999; 464():211-20. PubMed ID: 10335396 [TBL] [Abstract][Full Text] [Related]
18. Recombinant antithrombin: production and role in cardiovascular disorder. Levy JH; Weisinger A; Ziomek CA; Echelard Y Semin Thromb Hemost; 2001 Aug; 27(4):405-16. PubMed ID: 11547363 [TBL] [Abstract][Full Text] [Related]
19. Biomarkers: diagnostic highlights and surrogate end points. Cambridge Healthtech Institute's biomarker series: biomarker validation: bringing discovery to the clinic & cancer biomarkers: from discovery to clinical practice. May 3-5, 2004, Philadelphia, Pennsylvania, USA. Levenson VV Pharmacogenomics; 2004 Jul; 5(5):459-61. PubMed ID: 15212582 [No Abstract] [Full Text] [Related]
20. Generation and production of engineered antibodies. Kipriyanov SM; Le Gall F Mol Biotechnol; 2004 Jan; 26(1):39-60. PubMed ID: 14734823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]